Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,866 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of core needle biopsy number on intraductal carcinoma of the prostate (IDC-P) diagnosis in patients with metastatic hormone-sensitive prostate cancer.
Kato M, Hirakawa A, Kobayashi Y, Yamamoto A, Naito Y, Tochigi K, Sano T, Ishida S, Funahashi Y, Fujita T, Matsukawa Y, Hattori R, Tsuzuki T. Kato M, et al. Among authors: naito y. Int J Clin Oncol. 2020 Dec;25(12):2130-2137. doi: 10.1007/s10147-020-01756-0. Epub 2020 Aug 3. Int J Clin Oncol. 2020. PMID: 32748295
The clinical benefit of sequential therapy with androgen receptor axis-targeted agents alone in patients with castration-resistant prostate cancer: A propensity score-matched comparison study.
Naito Y, Kato M, Kawanishi H, Yuguchi Y, Yuba T, Ishikawa T, Hattori K, Yamamoto A, Sano T, Matsukawa Y, Kimura T, Nishikimi T, Hattori R, Tsuzuki T, Gotoh M. Naito Y, et al. Prostate. 2020 Nov;80(15):1373-1380. doi: 10.1002/pros.24069. Epub 2020 Sep 11. Prostate. 2020. PMID: 32914895
Grade group 2 (10% ≥ GP4) patients have very similar malignant potential with grade group 1 patients, given the risk of intraductal carcinoma of the prostate.
Kato M, Hirakawa A, Sato H, Hanazawa R, Naito Y, Tochigi K, Sano T, Ishida S, Funahashi Y, Fujita T, Matsukawa Y, Hattori R, Tsuzuki T. Kato M, et al. Among authors: naito y. Int J Clin Oncol. 2021 Apr;26(4):764-769. doi: 10.1007/s10147-020-01841-4. Epub 2021 Jan 1. Int J Clin Oncol. 2021. PMID: 33385274
2,866 results